CN105343760A - Traditional Chinese medicine for treating neurasthenia - Google Patents
Traditional Chinese medicine for treating neurasthenia Download PDFInfo
- Publication number
- CN105343760A CN105343760A CN201410416855.2A CN201410416855A CN105343760A CN 105343760 A CN105343760 A CN 105343760A CN 201410416855 A CN201410416855 A CN 201410416855A CN 105343760 A CN105343760 A CN 105343760A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- traditional chinese
- ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating neurasthenia and belongs to the technical field of a traditional Chinese medicine for treating neurasthenia. The traditional Chinese medicine comprises the following raw materials (by weight): 15-20 parts of radix bupleuri, 20-30 parts of radix curcumae, 15-30 parts of polygala root, 10-20 parts of white peony root, 8-12 parts of silktree flower, 9-15 parts of periostracum cicada, 9-14 parts of anemarrhena, 18-35 parts of uncaria, 15-30 parts of Huai wheat, 5-10 parts of common selfheal fruit-spike, 10-16 parts of tuber fleeceflower stem, 4-8 parts of ganoderma lucidum, 9-14 parts of radix ophiopogonis, 8-15 parts of semen cuscutae, 6-9 parts of Ganoderma applanatum Pat and 7-9 parts of oyster shell powder. The traditional Chinese medicine of the invention has a good treatment effect, has no side effect on body and is low-cost. After treatment, neurasthenia is not easy to recur. The traditional Chinese medicine has good treatment effects, can reduce toxic and side effect on human body, is suitable for long-term use and can obviously improve symptoms after being taken.
Description
Technical field
The present invention relates to one and treat neurasthenic Chinese medicine, belong to the neurasthenic technical field of Chinese medicines for the treatment of.
Background technology
Neurasthenia refers to due under being in nervous and pressure for a long time, occurs spirit easily excitement and mental easy tired phenomenon, often with emotion worry, irritability, sleep disorder, muscle tone pain etc.; These symptoms can not be attributed to brain, physical disease and other mental sickness.Heavy time light during symptom, fluctuate relevant with psychosocial factor, the many delays of the course of disease.Neurasthenia belongs to a kind of chronic disease, if long-term taking Western medicine can cause larger infringement to health, and existing treatment by Chinese herbs poor effect.
Summary of the invention
The object of the invention is to the weak point solving the existence of above-mentioned prior art, provide a kind of therapeutic effect good, can reduce the toxic and side effects to human body, suitable long-term taking, obviously can improve the neurasthenic Chinese medicine for the treatment of of symptom after taking.
One treats neurasthenic Chinese medicine, and its special character is to comprise following proportioning raw materials:
Radix Bupleuri 15-20 part, Radix Curcumae 20-30 part, Radix Polygalae 15-30 part, Radix Paeoniae Alba 10-20 part, Flos Albiziae 8-12 part, Periostracum Cicadae 9-15 part, Rhizoma Anemarrhenae 9-14 part, Ramulus Uncariae Cum Uncis 18-35 part, Huai wheat 15-30 part, Spica Prunellae 5-10 part, Caulis Polygoni Multiflori 10-16 part, Ganoderma 4-8 part, Radix Ophiopogonis 9-14 part, Semen Cuscutae 8-15 part, Ganoderma applanatum (Pers. Ex Wallr) Pat. 6-9 part, oyster shell powder 7-9 part;
Preferably, the neurasthenic Chinese medicine for the treatment of of the present invention, comprises following proportioning raw materials: Radix Bupleuri 17 parts, Radix Curcumae 25 parts, Radix Polygalae 22 parts, the Radix Paeoniae Alba 15 parts, Flos Albiziae 10 parts, Periostracum Cicadae 12 parts, the Rhizoma Anemarrhenae 11 parts, Ramulus Uncariae Cum Uncis 25 parts, Huai wheat 25 parts, Spica Prunellae 7 parts, Caulis Polygoni Multiflori 14 parts, Ganoderma 6 parts, Radix Ophiopogonis 11 parts, Semen Cuscutae 11 parts, Ganoderma applanatum (Pers. Ex Wallr) Pat. 7 parts, oyster shell powder 8 parts;
In order to reach better therapeutic effect, in described raw material, also comprise following Chinese medicine:
Rhizoma Acori Graminei 9-18 part, Radix Polygalae 9-14 part, Caulis Bambusae In Taenia 10-14 part.
The neurasthenic Chinese medicine for the treatment of of the present invention, proves through a large amount of research experiment of applicant, Caulis Polygoni Multiflori, Ganoderma, Radix Ophiopogonis three taste Chinese medicine mutually work in coordination with, there is special effect to mood placating, there is effect that is relieving convulsion, that releive, then coordinate other several Chinese medicines, cooperatively interact, result of use is very good.
Detailed description of the invention
Below provide the specific embodiment of the present invention, be used for that the present invention is described further.
Embodiment 1
The one of the present embodiment treats neurasthenic Chinese medicine, comprises following proportioning raw materials:
Radix Bupleuri 15 parts, Radix Curcumae 20 parts, Radix Polygalae 15 parts, the Radix Paeoniae Alba 10 parts, Flos Albiziae 8 parts, Periostracum Cicadae 9 parts, the Rhizoma Anemarrhenae 9 parts, Ramulus Uncariae Cum Uncis 18 parts, Huai wheat 15 parts, Spica Prunellae 5 parts, Caulis Polygoni Multiflori 10 parts, Ganoderma 4 parts, Radix Ophiopogonis 9 parts, Semen Cuscutae 8 parts, Ganoderma applanatum (Pers. Ex Wallr) Pat. 6 parts, oyster shell powder 7 parts.
Embodiment 2
The one of the present embodiment treats neurasthenic Chinese medicine, comprises following proportioning raw materials:
Radix Bupleuri 20 parts, Radix Curcumae 30 parts, Radix Polygalae 30 parts, the Radix Paeoniae Alba 20 parts, Flos Albiziae 12 parts, Periostracum Cicadae 15 parts, the Rhizoma Anemarrhenae 14 parts, Ramulus Uncariae Cum Uncis 35 parts, Huai wheat 30 parts, Spica Prunellae 10 parts, Caulis Polygoni Multiflori 16 parts, Ganoderma 8 parts, Radix Ophiopogonis 14 parts, Semen Cuscutae 15 parts, Ganoderma applanatum (Pers. Ex Wallr) Pat. 9 parts, oyster shell powder 9 parts, Rhizoma Acori Graminei 18 parts, Radix Polygalae 14 parts, Caulis Bambusae In Taenia 14 parts.
Embodiment 3
The one of the present embodiment treats neurasthenic Chinese medicine, comprises following proportioning raw materials:
Radix Bupleuri 17 parts, Radix Curcumae 25 parts, Radix Polygalae 22 parts, the Radix Paeoniae Alba 15 parts, Flos Albiziae 10 parts, Periostracum Cicadae 12 parts, the Rhizoma Anemarrhenae 11 parts, Ramulus Uncariae Cum Uncis 25 parts, Huai wheat 25 parts, Spica Prunellae 7 parts, Caulis Polygoni Multiflori 14 parts, Ganoderma 6 parts, Radix Ophiopogonis 11 parts, Semen Cuscutae 11 parts, Ganoderma applanatum (Pers. Ex Wallr) Pat. 7 parts, oyster shell powder 8 parts, Rhizoma Acori Graminei 18 parts, Radix Polygalae 14 parts, Caulis Bambusae In Taenia 14 parts.
The neurasthenic Chinese medicine for the treatment of of the present invention, proves through a large amount of research experiment of applicant, Caulis Polygoni Multiflori, Ganoderma, Radix Ophiopogonis three taste Chinese medicine mutually work in coordination with, there is special effect to mood placating, there is effect that is relieving convulsion, that releive, then coordinate other several Chinese medicines, cooperatively interact, result of use is very good.
Claims (3)
1. treat a neurasthenic Chinese medicine, it is characterized in that comprising following proportioning raw materials:
Radix Bupleuri 15-20 part, Radix Curcumae 20-30 part, Radix Polygalae 15-30 part, Radix Paeoniae Alba 10-20 part, Flos Albiziae 8-12 part, Periostracum Cicadae 9-15 part, Rhizoma Anemarrhenae 9-14 part, Ramulus Uncariae Cum Uncis 18-35 part, Huai wheat 15-30 part, Spica Prunellae 5-10 part, Caulis Polygoni Multiflori 10-16 part, Ganoderma 4-8 part, Radix Ophiopogonis 9-14 part, Semen Cuscutae 8-15 part, Ganoderma applanatum (Pers. Ex Wallr) Pat. 6-9 part, oyster shell powder 7-9 part.
2. treat neurasthenic Chinese medicine according to one according to claim 1, it is characterized in that treating neurasthenic Chinese medicine, comprise following proportioning raw materials: Radix Bupleuri 17 parts, Radix Curcumae 25 parts, Radix Polygalae 22 parts, the Radix Paeoniae Alba 15 parts, Flos Albiziae 10 parts, Periostracum Cicadae 12 parts, the Rhizoma Anemarrhenae 11 parts, Ramulus Uncariae Cum Uncis 25 parts, Huai wheat 25 parts, Spica Prunellae 7 parts, Caulis Polygoni Multiflori 14 parts, Ganoderma 6 parts, Radix Ophiopogonis 11 parts, Semen Cuscutae 11 parts, Ganoderma applanatum (Pers. Ex Wallr) Pat. 7 parts, oyster shell powder 8 parts.
3. treat neurasthenic Chinese medicine according to one according to claim 1, it is characterized in that also comprising following Chinese medicine in described raw material: Rhizoma Acori Graminei 9-18 part, Radix Polygalae 9-14 part, Caulis Bambusae In Taenia 10-14 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410416855.2A CN105343760A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine for treating neurasthenia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410416855.2A CN105343760A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine for treating neurasthenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105343760A true CN105343760A (en) | 2016-02-24 |
Family
ID=55319919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410416855.2A Pending CN105343760A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine for treating neurasthenia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105343760A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106237135A (en) * | 2016-08-22 | 2016-12-21 | 周舜宁 | One treats the neurasthenic Chinese medicine of type of deficiency of YIN leading to hyper activity of YANG |
| CN108338242A (en) * | 2017-01-23 | 2018-07-31 | 上海市浦东新区精神卫生中心 | Intelligence development tea |
-
2014
- 2014-08-22 CN CN201410416855.2A patent/CN105343760A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106237135A (en) * | 2016-08-22 | 2016-12-21 | 周舜宁 | One treats the neurasthenic Chinese medicine of type of deficiency of YIN leading to hyper activity of YANG |
| CN108338242A (en) * | 2017-01-23 | 2018-07-31 | 上海市浦东新区精神卫生中心 | Intelligence development tea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY170194A (en) | Pharmaceutical composition for treating insomnia and preparation method thereof | |
| CN105343760A (en) | Traditional Chinese medicine for treating neurasthenia | |
| CN104922264A (en) | Traditional Chinese medicine special for treating rheumatism | |
| CN103566322A (en) | Medicine for treating chronic diarrhea | |
| CN104491305A (en) | Traditional Chinese medicine composition for treating anxiety neurasthenia | |
| CN104398915A (en) | Traditional Chinese medicinal composition for chronic eczema | |
| CN104288295A (en) | Traditional Chinese medicinal composition for treating swollen sore throat | |
| CN103566151A (en) | Medicament for treating neurodermatitis | |
| CN103536792B (en) | A kind of Chinese prescription for the treatment of climacteric syndrome and preparation method thereof | |
| CN107823412A (en) | A kind of cough relief traditional Chinese medicine formula | |
| CN105641336A (en) | Traditional Chinese medicine oral medicament for treating acne | |
| CN105878457A (en) | Medical wine | |
| CN104771598A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN104116959A (en) | Medicine for treating chronic cough | |
| CN104758576A (en) | Traditional Chinese medicine composition for treating neurasthenia in the type of yin deficiency of liver and kidney | |
| CN104721690A (en) | Oral drug for treatment of gastroenteritis | |
| CN104740048A (en) | Treatment method for periarthritis of shoulder | |
| CN103721209A (en) | Traditional Chinese medicine prescription for treating leukorrhea diseases caused by exuberance of interior dampness-heat | |
| CN103784859A (en) | Emplastrum for treating cervical spondylosis | |
| CN103520402A (en) | Drug used for treating iron deficiency anemia | |
| CN104740271A (en) | Traditional Chinese medicine preparation for treating acute cholecystitis | |
| CN104415294A (en) | Medicinal liquor capable of preventing neurasthenia | |
| CN105456811A (en) | Traditional Chinese medicine for treating diphtheria | |
| CN106511683A (en) | Traditional Chinese medicinal prescription for treating fatty liver | |
| CN106334095A (en) | Traditional Chinese medicine composition for treating chronic vocal cord sphagitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160224 |